RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Pharma-Bio Serv Stock

Pharma-Bio Serv ROCE 2024

Pharma-Bio Serv ROCE

0.07

Ticker

PBSV

ISIN

US71711N1000

In 2024, Pharma-Bio Serv's return on capital employed (ROCE) was 0.07, a -2.36% increase from the 0.07 ROCE in the previous year.

Pharma-Bio Serv Aktienanalyse

What does Pharma-Bio Serv do?

Pharma-Bio Serv Inc is an international company based in Puerto Rico that was founded in 1993. The company offers a wide range of high-quality services to the pharmaceutical, biotech, and hospital industries and has become a leading service provider in this field. Pharma-Bio Serv ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Pharma-Bio Serv's Return on Capital Employed (ROCE)

Pharma-Bio Serv's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Pharma-Bio Serv's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Pharma-Bio Serv's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Pharma-Bio Serv’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Pharma-Bio Serv stock

What is the ROCE (Return on Capital Employed) of Pharma-Bio Serv this year?

The ROCE of Pharma-Bio Serv is 0.07 undefined this year.

How has the ROCE (Return on Capital Employed) of Pharma-Bio Serv developed compared to the previous year?

The ROCE of Pharma-Bio Serv has increased by -2.36% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Pharma-Bio Serv?

A high Return on Capital Employed (ROCE) indicates that Pharma-Bio Serv has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Pharma-Bio Serv?

A low ROCE (Return on Capital Employed) can indicate that Pharma-Bio Serv has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Pharma-Bio Serv impact the company?

An increase in the ROCE of Pharma-Bio Serv can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Pharma-Bio Serv affect the company?

A decrease in ROCE of Pharma-Bio Serv can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Pharma-Bio Serv?

Some factors that can affect Pharma-Bio Serv's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Pharma-Bio Serv so important for investors?

The ROCE of Pharma-Bio Serv is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Pharma-Bio Serv take to improve the ROCE?

To improve the ROCE, Pharma-Bio Serv can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Pharma-Bio Serv pay?

Over the past 12 months, Pharma-Bio Serv paid a dividend of 0.15 USD . This corresponds to a dividend yield of about 23.47 %. For the coming 12 months, Pharma-Bio Serv is expected to pay a dividend of 0.15 USD.

What is the dividend yield of Pharma-Bio Serv?

The current dividend yield of Pharma-Bio Serv is 23.47 %.

When does Pharma-Bio Serv pay dividends?

Pharma-Bio Serv pays a quarterly dividend. This is distributed in the months of January, March, April, February.

How secure is the dividend of Pharma-Bio Serv?

Pharma-Bio Serv paid dividends every year for the past 5 years.

What is the dividend of Pharma-Bio Serv?

For the upcoming 12 months, dividends amounting to 0.15 USD are expected. This corresponds to a dividend yield of 22.81 %.

In which sector is Pharma-Bio Serv located?

Pharma-Bio Serv is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pharma-Bio Serv kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pharma-Bio Serv from 2/15/2024 amounting to 0.075 USD, you needed to have the stock in your portfolio before the ex-date on 1/29/2024.

When did Pharma-Bio Serv pay the last dividend?

The last dividend was paid out on 2/15/2024.

What was the dividend of Pharma-Bio Serv in the year 2023?

In the year 2023, Pharma-Bio Serv distributed 0.075 USD as dividends.

In which currency does Pharma-Bio Serv pay out the dividend?

The dividends of Pharma-Bio Serv are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Pharma-Bio Serv

Our stock analysis for Pharma-Bio Serv Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pharma-Bio Serv Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.